Volitionrx (VNRX) Depreciation & Amortization (CF) (2011 - 2025)
Volitionrx's (VNRX) quarterly Depreciation & Amortization (CF) came in at $230824.0 in Q4 2025, down 21.92% YoY from $295642.0 in Q4 2024, and down 7.02% on a QoQ basis from $248253.0 in Q3 2025.
Volitionrx (VNRX) Depreciation & Amortization (CF) (2011 - 2025) Analysis & Trends
Volitionrx (VNRX) has 15 years of Depreciation & Amortization (CF) data on file, last reported at $230824.0 in Q4 2025.
- Quarterly Depreciation & Amortization (CF) fell 21.92% year-over-year to $230824.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $983706.0 (down 11.63% YoY) and the FY2025 annual result came in at $983706.0, down 11.63% from the prior year.
- Depreciation & Amortization (CF) retreated to $230824.0 in Q4 2025, from $248253.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $296587.0 in Q4 2023 to a low of $224310.0 in Q1 2022.
- A 5-year average of $256543.8 and a median of $250454.5 in 2022 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2021 — Depreciation & Amortization (CF) soared 42.7% — and 2025, when it dropped 21.92%.
- Tracing VNRX's Depreciation & Amortization (CF) over 5 years: stood at $236847.0 in 2021, then rose by 5.12% to $248968.0 in 2022, then gained by 19.13% to $296587.0 in 2023, then declined by 0.32% to $295642.0 in 2024, then retreated by 21.92% to $230824.0 in 2025.
- The last three Depreciation & Amortization (CF) figures came in at $230824.0 (Q4 2025), $248253.0 (Q3 2025), and $252688.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Volitionrx | 1.19 Mn | -1.60 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 230,824.00 |
| Dec 31, 2025 | 230,824.00 |
| Sep 30, 2025 | 248,253.00 |
| Sep 30, 2025 | 248,253.00 |
| Jun 30, 2025 | 252,688.00 |
| Jun 30, 2025 | 252,688.00 |
| Mar 31, 2025 | 251,941.00 |
| Mar 31, 2025 | 251,941.00 |
| Dec 31, 2024 | 295,642.00 |
| Dec 31, 2024 | 295,642.00 |
| Sep 30, 2024 | 285,038.00 |
| Sep 30, 2024 | 285,038.00 |
| Jun 30, 2024 | 269,297.00 |
| Jun 30, 2024 | 269,297.00 |
| Mar 31, 2024 | 263,207.00 |
| Mar 31, 2024 | 263,207.00 |
| Dec 31, 2023 | 296,587.00 |
| Dec 31, 2023 | 296,587.00 |
| Sep 30, 2023 | 295,634.00 |
| Sep 30, 2023 | 295,634.00 |